Wednesday Jul 16
Insider Selling: Kimberly J. Popovits Sells 3,000 Shares of Genomic Health Stock
Genomic Health CEO Kimberly J. Popovits unloaded 3,000 shares of the stock in a transaction dated Monday, July 14th.
Genomic Health Receives Average Rating of "Hold" from Brokerages
Shares of Genomic Health have earned a consensus recommendation of "Hold" from the twelve ratings firms that are covering the stock, AnalystRatingsNetwork reports .
Insider Selling: Genomic Health EVP Sells 7,000 Shares of Stock
Genomic Health EVP Steven Shak sold 7,000 shares of the company's stock in a transaction dated Tuesday, July 1st.
Camber Capital Management Adds To Position In Genomic Health, Inc.
Stephen Dubois is optimistic about the prospects of Genomic Health, Inc. and has increased his fund's holding of the stock.